Pang D - Search Results

1

The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1.

Li H, Xiao Y, Li Q, Yao J, Yuan X, Zhang Y, Yin X, Saito Y, Fan H, Li P, Kuo WL, Halpin A, Gibbons DL, Yagita H, Zhao Z, Pang D, Ren G, Yee C, Lee JJ, Yu D. Li H, et al. Among authors: pang d. Cancer Cell. 2022 Jan 10;40(1):36-52.e9. doi: 10.1016/j.ccell.2021.11.002. Epub 2021 Nov 24. Cancer Cell. 2022. PMID: 34822775 Free PMC article.

2

Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation.

Lee HH, Wang YN, Yang WH, Xia W, Wei Y, Chan LC, Wang YH, Jiang Z, Xu S, Yao J, Qiu Y, Hsu YH, Hwang WL, Yan M, Cha JH, Hsu JL, Shen J, Ye Y, Wu X, Hou MF, Tseng LM, Wang SC, Pan MR, Yang CH, Wang YL, Yamaguchi H, Pang D, Hortobagyi GN, Yu D, Hung MC. Lee HH, et al. Among authors: pang d. Nat Commun. 2021 May 13;12(1):2788. doi: 10.1038/s41467-021-23075-2. Nat Commun. 2021. PMID: 33986289 Free PMC article.

3

High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer.

Zhang Y, Cheng S, Zhang M, Zhen L, Pang D, Zhang Q, Li Z. Zhang Y, et al. Among authors: pang d. PLoS One. 2013 Sep 30;8(9):e76147. doi: 10.1371/journal.pone.0076147. eCollection 2013. PLoS One. 2013. PMID: 24098773 Free PMC article.

4

B7-H4 expression in human infiltrating ductal carcinoma‑associated macrophages.

Liu L, Li D, Chen S, Zhao R, Pang D, Li D, Fu Z. Liu L, et al. Among authors: pang d. Mol Med Rep. 2016 Sep;14(3):2135-42. doi: 10.3892/mmr.2016.5510. Epub 2016 Jul 13. Mol Med Rep. 2016. PMID: 27430170

5

HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance.

Zhang Y, Zhang Q, Cao Z, Huang Y, Cheng S, Pang D. Zhang Y, et al. Among authors: pang d. Cell Physiol Biochem. 2018;46(4):1737-1747. doi: 10.1159/000489249. Epub 2018 Apr 23. Cell Physiol Biochem. 2018. PMID: 29698974 Free article.

6

Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer.

Xu S, Wang P, Zhang J, Wu H, Sui S, Zhang J, Wang Q, Qiao K, Yang W, Xu H, Pang D. Xu S, et al. Among authors: pang d. Mol Cancer. 2019 Apr 18;18(1):89. doi: 10.1186/s12943-019-1017-z. Mol Cancer. 2019. PMID: 30999914 Free PMC article.

7

Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer.

Xu S, Wang Q, Kang Y, Liu J, Yin Y, Liu L, Wu H, Li S, Sui S, Shen M, Zheng W, Pang D. Xu S, et al. Among authors: pang d. Cancer Immunol Res. 2020 Jul;8(7):937-951. doi: 10.1158/2326-6066.CIR-19-0696. Epub 2020 Apr 22. Cancer Immunol Res. 2020. PMID: 32321773

8

Targeting RNA N⁶-methyladenosine modification: a precise weapon in overcoming tumor immune escape.

Li W, Hao Y, Zhang X, Xu S, Pang D. Li W, et al. Among authors: pang d. Mol Cancer. 2022 Sep 7;21(1):176. doi: 10.1186/s12943-022-01652-3. Mol Cancer. 2022. PMID: 36071523 Free PMC article. Review.

9

ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control study.

Xu F, Li D, Zhang Q, Fu Z, Zhang J, Yuan W, Chen S, Pang D, Li D. Xu F, et al. Among authors: pang d. BMC Cancer. 2011 Sep 15;11:392. doi: 10.1186/1471-2407-11-392. BMC Cancer. 2011. PMID: 21917182 Free PMC article.

10

Low expression of RECK indicates a shorter survival for patients with invasive breast cancer.

Zhang Y, Cheng S, Zhang G, Ma W, Liu Y, Zhao R, Zhang Q, Pang D. Zhang Y, et al. Among authors: pang d. Cancer Sci. 2012 Jun;103(6):1084-9. doi: 10.1111/j.1349-7006.2012.02265.x. Epub 2012 Apr 19. Cancer Sci. 2012. PMID: 22404079 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,405 results

Search Page